Frontlight ResearchEarly access
CompletedNo phase
COREV 2.0 PMCF-Study on Manual and Navigated Revision Knee Patients
Key facts
- Who runs it
- Aesculap AG
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 100 people enrolled
- Started
- 16 Mar 2022
- Ended
- 24 Mar 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Navigated Revision Total Knee Arthroplasty
- Manual Revision Total Knee Arthroplasty
- Record updated
- 14 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patient underwent navigated revision surgery using the Columbus® Revision knee prosthesis (case group)
- Patient underwent conventional manual revision surgery using another implant system (control group)
- Written informed consent
Who cannot take part
- Allergy to any prosthesis component
- Patient Age at time of revision surgery < 18 years
- Pregnancy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The Columbus® Revision endoprosthetic system is bearing the CE-mark. This means that within the scope of this observational study the patient will not be subjected to any additional stressful, study-related medical examinations or treatment measures. The treatment will be carried out exclusively according to medical standards. The study therefore only serves the purpose of observing this standard-compliant treatment and specifically documenting it scientifically.
The 2 groups in the trial
- navigation assisted knee revision surgery
Treatment: Navigated Revision Total Knee Arthroplasty
- manual procedure
Treatment: Manual Revision Total Knee Arthroplasty
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparative, Case Control, Mono-center PMCF Study on Manual and Navigated Revision Knee Patients After a Minimum Follow-Up of Two Years
- Record updated
- 14 August 2025